By: Dr. Vijay Ramanan Haemophilia B constitutes a severe rare genetic bleeding condition which interferes strongly with blood ...

Belief BioMed and Takeda China today jointly announced that BBM-H901, has been officially approved by the National Medical ...

You must have noticed that when you get injured, your blood turns to a gel, forming a blood clot. This mess your body is healing well. However, if you have haemophilia B, your blood won’t be able to ...

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.

The FDA has approved fitusiran, now Qfitlia, as a treatment for hemophilia A or B patients, ages 12 and older, with or without inhibitors.

FEIBA (factor eight inhibitor bypassing activity), also known as activated prothrombin complex ... while the lack of factor IX, known as FIX, is associated with hemophilia B. As a bypassing agent, ...

As of the May 7, 2018 data cutoff, all 13 participants with at least 12 weeks of follow-up after SPK-9001 infusion, the length of time required to achieve steady-state factor IX activity ...

Between our long-term i7 and iX, it was the latter that everyone was after, but I still managed to hang on to the iX for over a month, and what an interesting month it was! Living with a large car ...

March 25 (UPI) --A male competing against females and using a girls locker room while girls were changing clothing spurred a Department of Education investigation of possible Title IX violations ...

Title IX protects individuals from exclusion or discrimination on the basis of sex under any education program or activity receiving federal financial assistance. Acting Assistant Secretary for ...